Research Summary
Analyzed using Evidence Intelligence™

Switching GDM criteria shows no significant effect on pregnancy outcomes

Last updated September 9, 2026

Key finding

Adjusted risk ratio (aRR) of 0.97 (95% CI 0.91 to 1.02, p = 0.26)

This study evaluated the impact of switching to WHO-2013 criteria for diagnosing gestational diabetes mellitus (GDM) and found no significant change in large for gestational age (LGA) outcomes.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the impact of switching to WHO-2013 criteria for diagnosing gestational diabetes mellitus (GDM) and found no significant change in large for gestational age (LGA) outcomes.

Clinical relevance

Understanding the implications of diagnostic criteria for gestational diabetes is crucial for maternal and neonatal health. This study's findings suggest that the transition to WHO-2013 criteria does not increase the risk of having larger babies, which can lead to complications during delivery. Clinicians can feel reassured that adopting these criteria will not negatively impact birth outcomes.

Keep in mind

The study's effectiveness was unclear due to non-significant findings. Limited generalizability as the population may not represent all demographics. Potential unmeasured confounders affecting outcomes. The sample size may limit the power to detect smaller effects.

Published in

Journal Reference

Publication details and source links for this paper.

Maryam DB, Anders M, Scott M, et al. Switching Diagnostic Criteria for Gestational Diabetes Mellitus: A Stepped Wedge Cluster Randomized Trial. PLOS Medicine. 2024;21(7):e1004420. doi:10.1371/journal.pmed.1004420

Main Effects

No significant change in LGA rates (11.5% vs 11.4%) after switching criteria.

Adjusted risk ratio for LGA was 0.97 (95% CI 0.91 to 1.02, p = 0.26).

In a discordant subgroup, LGA prevalence decreased from 28.8% to 22.5%, aRR 0.87 (p = 0.076).

No serious maternal or neonatal complications were reported.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Switch to WHO-2013 GDM criteria and Adjusted risk ratio for LGA, Bacteroidaceae levels in standard diet group, Neonatal complications, and 1 more.

Primary intervention

Switch to WHO-2013 GDM criteria

Primary outcomes

  • Adjusted risk ratio for LGA
  • Bacteroidaceae levels in standard diet group
  • Neonatal complications

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 50

0

Related topics

4

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

Adjusted risk ratio for LGA

Switch to WHO-2013 GDM criteria → Adjusted risk ratio for LGA

Switch to WHO-2013 GDM criteria → Adjusted risk ratio for LGA

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Bacteroidaceae levels in standard diet group

Switch to WHO-2013 GDM criteria → Bacteroidaceae levels in standard diet group

Switch to WHO-2013 GDM criteria → Bacteroidaceae levels in standard diet group

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Neonatal complications

Switch to WHO-2013 GDM criteria → Neonatal complications

Switch to WHO-2013 GDM criteria → Neonatal complications

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Proportion of large-for-gestational-age newborns

Switch to WHO-2013 GDM criteria → Proportion of large-for-gestational-age newborns

Switch to WHO-2013 GDM criteria → Proportion of large-for-gestational-age newborns

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • LGA rates remained stable with the new diagnostic criteria (11.5% vs 11.4%).
  • Adjusted risk ratio for LGA was 0.97, indicating no significant difference.
  • In a specific subgroup, LGA prevalence decreased from 28.8% to 22.5%.
who this applies

Who this applies to

  • Pregnant individuals diagnosed with gestational diabetes.
  • Women in the perinatal period at risk for large for gestational age infants.
keep in mind

Keep in Mind

  • Results may not apply to all populations due to specific study demographics.
  • The lack of significant findings suggests caution in interpreting effectiveness.
  • Further research may be needed to explore long-term outcomes.
  • The study did not report any serious complications, which is a positive aspect.
between the lines

Between the Lines

  • The study's effectiveness was unclear due to non-significant findings.
  • Limited generalizability as the population may not represent all demographics.
  • Potential unmeasured confounders affecting outcomes.
  • The sample size may limit the power to detect smaller effects.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Switch to WHO-2013 GDM criteria and Adjusted risk ratio for LGA, Switch to WHO-2013 GDM criteria and Bacteroidaceae levels in standard diet group.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Switch to WHO-2013 GDM criteria reduce adjusted risk ratio for lga?

Emerging Evidence

Current evidence does not show a clear reduction in adjusted risk ratio for lga with Switch to WHO-2013 GDM criteria.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adjusted risk ratio for LGA

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Switch to WHO-2013 GDM criteria improve bacteroidaceae levels in standard diet group?

Emerging Evidence

Current evidence does not show a clear benefit of Switch to WHO-2013 GDM criteria for bacteroidaceae levels in standard diet group.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Bacteroidaceae levels in standard diet group

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Switch to WHO-2013 GDM criteria improve neonatal complications?

Emerging Evidence

Current evidence does not show a clear benefit of Switch to WHO-2013 GDM criteria for neonatal complications.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Neonatal complications

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Switch to WHO-2013 GDM criteria improve proportion of large-for-gestational-age newborns?

Emerging Evidence

Current evidence does not show a clear benefit of Switch to WHO-2013 GDM criteria for proportion of large-for-gestational-age newborns.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Proportion of large-for-gestational-age newborns

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.